USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Transformation, Developments, Opportunities and Future of CRO Market
04-Feb-2015
Global
Market Research
P846-01-00-00-00
LS00143-GL-MR_16984
This research service presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type, and region. It addresses the major issues and challenges, unmet needs, and emerging trends in the market. Detailed information has been provided on support services such as Central Laboratory services, Bio analytics, and Data management. It also outlines market drivers and restraints, market engineering measurements, and R&D trends. The report covers the complete life cycle of the CRO industry, starting from preclinical trials to post marketing surveillance. It highlights emerging trends and their importance in the current and future market scenario. Apart from preclinical and clinical segments it also focuses on the emerging trends than can be seen in the CRO space. One of the focus areas of this study is bio analytics services, which is making a big impact in the CRO industry. Earlier, pre-clinical and early phase research were handled by pharma companies themselves, but now, due to the high cost and risk involved, the big companies have started to look for partners, giving rise to Bio analytics focused CROs.
Key Findings
Key Findings (continued)
Key Findings (continued)
Key Findings (continued)
Key Findings (continued)
Global CRO Market Size by Clinical Development Stage
Market Size Estimation Methodology
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
Market Engineering Measurements (continued)
CEO’s Perspective
Key Companies to Watch
Key Companies to Watch (continued)
3 Big Predictions
Global R&D Spending—Pharmaceutical Drug Development
Global R&D Market Landscape
Global Market Perspective
CRO Product Development and Commercialization
Market Segmentation by Clinical Development Stage
Market Segmentation by Clinical Development Stage (continued)
Market Segmentation by Therapeutic Services
Market Segmentation by Geography
Global CRO Key Market Trends
eClinical Solutions
eClinical Solutions—Applications and Technologies
Rise of Virtual Business Models
New Market Opportunities
New Market Opportunities (continued)
New Market Opportunities (continued)
Global CRO Industry—Major Stake Holders
Global CRO Competitive Matrix
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Market Drivers
Drivers Explained
Drivers Explained (continued)
Market Restraints
Restraints Explained
Restraints Explained (continued)
Forecast Assumptions
Market Engineering Measurements
Market Engineering Measurements (continued)
Revenue Forecast
Revenue Forecast Discussion
Global CRO Key Market Trends
Global CRO Key Market Trends Explained
Global CRO Key Market Trends Explained (continued)
Global CRO Key Market Trends Explained (continued)
Competitive Analysis—Market Share
Market Share Analysis
Competitive Environment
Competitive Analysis—Selected Key Market Participants
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Preclinical Trials Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Preclinical Trials Segment Metrics Analysis
Preclinical Trials Segment Metrics Analysis (continued)
Preclinical Trials Segment Key Trends
Phase I Trials Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Phase I Trials Segment Metrics Analysis
Phase I Trials Segment Metrics Analysis (continued)
Phase I Trials Segment Key Trends
Phase II Trials Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Phase II Trials Segment Metrics Analysis
Phase II Trials Segment Metrics Analysis (continued)
Phase II Trials Segment Key Trends*
Phase III Trials Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Phase III Trials Segment Metrics Analysis
Phase III Trials Segment Metrics Analysis (continued)
Phase III Trials Segment Key Trends*
Phase IV Trials Segment Overview
Market Engineering Measurements
Revenue Forecast
Phase IV Trials Segment—Revenue Forecast Discussion
Phase IV Trials Segment Metrics Analysis
Phase IV Trials Segment Metrics Analysis (continued)
Phase IV Trials Segment Key Trends
Data Management Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast
Data Management Segment Metrics Analysis
Data Management Segment Metrics Analysis (continued)
Data Management Segment Key Trends
Biostatistics Segment Overview
Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Biostatistics Segment Metrics Analysis
Biostatistics Segment Metrics Analysis (continued)
Biostatistics Segment Key Trends
Pharmacovigilance Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Pharmacovigilance Segment Metrics Analysis
Pharmacovigilance Segment Metrics Analysis (continued)
Pharmacovigilance Segment Key Trends
HEOR Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
HEOR Segment Metrics Analysis
HEOR Segment Metrics Analysis (continued)
HEOR Segment Key Trends
Pharmaceuticals and Biotech Laboratory Testing Services Segment—Overview
Pharmaceuticals and Biotech Laboratory Services—Segmentation
Pharmaceuticals and Biotech Laboratory Testing Services—Segmentation (continued)
Pharmaceuticals and Biotech Laboratory Testing Services—Key Trends
Pharmaceuticals and Biotech Laboratory Services—Key Trends Explained
Pharmaceuticals and Biotech Laboratory Services—Key Trends Explained (continued)
cGMP Testing Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
cGMP Testing Segment Metrics Analysis
cGMP Testing Segment Metrics Analysis (continued)
Revenue Breakdown by Type of Services
Bio-analytical Testing Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Bio-analytical Testing Segment Metrics Analysis
Bio-analytical Testing Segment Metrics Analysis (continued)
Revenue Breakdown by Type of Services
Analytical Testing Services—Major Participants
Analytical Testing Services—Market Share
Analytical Testing Services—Market Share Analysis
Analytical Testing Services—Competitive Environment
Competitive Analysis—Selected Key Market Participants
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Competitive Analysis—Selected Key Market Participants (continued)
Central Laboratory Testing Segment Overview
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Central Laboratory Testing Segment Metrics Analysis
Central Laboratory Testing Segment Metrics Analysis (continued)
North America Breakdown
Segmentation by Clinical Development Stage
Segmentation by Therapeutic Services
North America CRO Market size by Clinical Development Stage
Market Engineering Measurements
Revenue Forecast
North America CRO Market—Revenue Forecast Discussion
Preclinical and Phase I Trials Segment—Revenue Forecast
Phase II and Phase III Trials Segment—Revenue Forecast
Phase IV Trials and Pharmacovigilance Segment—Revenue Forecast
Biostatistics and Data Management Segment—Revenue Forecast
Bio-analytical and Central Laboratory Testing Segment—Revenue Forecast
HEOR Segment—Revenue Forecast
Market Share
Europe Breakdown
Segmentation by Clinical Development Stage
Segmentation by Therapeutic Services
Europe CRO Market size by Clinical Development Stage
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Preclinical and Phase I Trials Segment—Revenue Forecast
Phase II and Phase III Trials Segment—Revenue Forecast
Phase IV Trials and Pharmacovigilance Segment—Revenue Forecast
Biostatistics and Data Management Segment—Revenue Forecast
Bio-analytical and Central Laboratory Testing Segment—Revenue Forecast
HEOR Segment—Revenue Forecast
Market Share
APAC Breakdown
Segmentation by Clinical Development Stage
Segmentation by Therapeutic Services
Market size by Clinical Development Stage
Market Engineering Measurements
Revenue Forecast
Revenue Forecast Discussion
Preclinical and Phase I Trials Segment—Revenue Forecast
Phase II and Phase III Trials Segment—Revenue Forecast
Phase IV Trials and Pharmacovigilance Segment—Revenue Forecast
Biostatistics and Data Management Segment—Revenue Forecast
Bio-analytical and Central Laboratory Testing Segment—Revenue Forecast
HEOR Segment—Revenue Forecast
Market Share
ROW Breakdown
Segmentation by Clinical Development Stage
Segmentation by Therapeutic Services
Market size by Clinical Development Stage
Market Engineering Measurements
Revenue Forecast
ROW CRO Market—Revenue Forecast Discussion
Preclinical and Phase I Trials Segment—Revenue Forecast
Phase II and Phase III Trials Segment—Revenue Forecast
Phase IV Trials and Pharmacovigilance Segment—Revenue Forecast
Biostatistics and Data Management Segment—Revenue Forecast
Bio-analytical and Central Laboratory Testing Segment—Revenue Forecast
HEOR Segment—Revenue Forecast
Market Share
3 Big Predictions
The Last Word—Discussion
Legal Disclaimer
Market Engineering Methodology
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Lightbox Content | World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019 |
| Author | Sanjeev Kumar |
| WIP Number | P846-01-00-00-00 |
| Is Prebook | No |
Global CRO Market
$4,950.00
Special Price $3,712.50 save 25 %